FI60392C - Foerfarande foer framstaellning av beta-(2-(p-klorfenoxi)-isobutyryloxi)-etylnikotinat - Google Patents
Foerfarande foer framstaellning av beta-(2-(p-klorfenoxi)-isobutyryloxi)-etylnikotinat Download PDFInfo
- Publication number
- FI60392C FI60392C FI752079A FI752079A FI60392C FI 60392 C FI60392 C FI 60392C FI 752079 A FI752079 A FI 752079A FI 752079 A FI752079 A FI 752079A FI 60392 C FI60392 C FI 60392C
- Authority
- FI
- Finland
- Prior art keywords
- chlorophenoxy
- isobutyryloxy
- reaction
- dimethylformamide
- chloride
- Prior art date
Links
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 17
- 229940064982 ethylnicotinate Drugs 0.000 description 15
- -1 p-chlorophenoxy Chemical group 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 11
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 10
- 239000011664 nicotinic acid Substances 0.000 description 10
- XBLVHTDFJBKJLG-UHFFFAOYSA-N nicotinic acid ethyl ester Natural products CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 235000001968 nicotinic acid Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- IUAXUYMFMHJWHL-UHFFFAOYSA-N 2-chloroethyl 2-(4-chlorophenoxy)-2-methylpropanoate Chemical compound ClCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 IUAXUYMFMHJWHL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 150000001447 alkali salts Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001348 alkyl chlorides Chemical class 0.000 description 2
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 2
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960003750 ethyl chloride Drugs 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- CEJKAKCQVUWNNA-UHFFFAOYSA-N 2-(4-chlorophenoxy)butanoic acid Chemical compound CCC(C(O)=O)OC1=CC=C(Cl)C=C1 CEJKAKCQVUWNNA-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- ZSJYACCQFXFYPQ-UHFFFAOYSA-N CCC1=C(C=CC(=N1)OC(=O)C(C)(C)OC2=CC=C(C=C2)Cl)C(=O)O Chemical compound CCC1=C(C=CC(=N1)OC(=O)C(C)(C)OC2=CC=C(C=C2)Cl)C(=O)O ZSJYACCQFXFYPQ-UHFFFAOYSA-N 0.000 description 1
- FHZZDGNMAAFBSG-UHFFFAOYSA-N ClC1=CC=C(OC(CCl)OC(C(C)C)=O)C=C1 Chemical compound ClC1=CC=C(OC(CCl)OC(C(C)C)=O)C=C1 FHZZDGNMAAFBSG-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3877874A GB1442474A (en) | 1974-09-05 | 1974-09-05 | Process for the production of beta-2-p-chlorophenoxy-isobutyryloxy -ethyl nicotinate |
| GB3877874 | 1974-09-05 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI752079A7 FI752079A7 (enrdf_load_stackoverflow) | 1976-03-06 |
| FI60392B FI60392B (fi) | 1981-09-30 |
| FI60392C true FI60392C (fi) | 1982-01-11 |
Family
ID=10405641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI752079A FI60392C (fi) | 1974-09-05 | 1975-07-18 | Foerfarande foer framstaellning av beta-(2-(p-klorfenoxi)-isobutyryloxi)-etylnikotinat |
Country Status (17)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4375545A (en) * | 1981-06-22 | 1983-03-01 | Westwood Pharmaceuticals, Inc. | Process for the synthesis of the nicotinyl ester of 6-aminonicotinic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2304405A1 (de) * | 1972-03-08 | 1973-09-13 | Hurka Wilhelm | Ester der p-chlorphenoxyisobuttersaeure und verfahren zu deren herstellung |
-
1974
- 1974-09-05 GB GB3877874A patent/GB1442474A/en not_active Expired
-
1975
- 1975-01-01 AR AR260267A patent/AR205658A1/es active
- 1975-07-12 DE DE19752531254 patent/DE2531254A1/de not_active Withdrawn
- 1975-07-18 FI FI752079A patent/FI60392C/fi not_active IP Right Cessation
- 1975-07-28 YU YU1923/75A patent/YU37132B/xx unknown
- 1975-07-30 AT AT591475A patent/AT344173B/de not_active IP Right Cessation
- 1975-08-06 NO NO752762A patent/NO752762L/no unknown
- 1975-08-21 BE BE159356A patent/BE832618R/xx active
- 1975-08-25 CA CA234,142A patent/CA1054153A/en not_active Expired
- 1975-08-29 DK DK390875A patent/DK145929C/da not_active IP Right Cessation
- 1975-08-30 JP JP50105573A patent/JPS597702B2/ja not_active Expired
- 1975-09-04 ES ES440711A patent/ES440711A1/es not_active Expired
- 1975-09-04 HU HUME1893A patent/HU169891B/hu not_active IP Right Cessation
- 1975-09-05 CH CH1151575A patent/CH584198A5/xx not_active IP Right Cessation
- 1975-09-05 PL PL1975183136A patent/PL97697B1/pl unknown
- 1975-09-05 FR FR7527367A patent/FR2283892A2/fr active Granted
- 1975-09-05 NL NL7510526A patent/NL7510526A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK390875A (da) | 1976-03-06 |
| NL7510526A (nl) | 1976-03-09 |
| PL97697B1 (pl) | 1978-03-30 |
| DK145929C (da) | 1983-09-26 |
| ES440711A1 (es) | 1977-03-16 |
| FR2283892A2 (fr) | 1976-04-02 |
| GB1442474A (en) | 1976-07-14 |
| FI752079A7 (enrdf_load_stackoverflow) | 1976-03-06 |
| CA1054153A (en) | 1979-05-08 |
| ATA591475A (de) | 1977-11-15 |
| YU192375A (en) | 1983-04-27 |
| DK145929B (da) | 1983-04-18 |
| HU169891B (enrdf_load_stackoverflow) | 1977-02-28 |
| JPS5168572A (en) | 1976-06-14 |
| AR205658A1 (es) | 1976-05-21 |
| NO752762L (enrdf_load_stackoverflow) | 1976-03-08 |
| JPS597702B2 (ja) | 1984-02-20 |
| FI60392B (fi) | 1981-09-30 |
| YU37132B (en) | 1984-08-31 |
| AT344173B (de) | 1978-07-10 |
| FR2283892B2 (enrdf_load_stackoverflow) | 1980-08-08 |
| DE2531254A1 (de) | 1976-03-25 |
| CH584198A5 (enrdf_load_stackoverflow) | 1977-01-31 |
| BE832618R (fr) | 1975-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4564686A (en) | Phosphoric acid diesters or their salts and process for producing the same | |
| JPS60260581A (ja) | １−（ヒドロキシメチル）−１，６，７，１１ｂ−テトラヒドロ−２Ｈ，４Ｈ−〔１，３〕オキサジノ−または−チアジノ〔４，３−ａ〕イソキノリン誘導体 | |
| DE102007045476A1 (de) | Neue heteroarylsubstituierte Acetonderivate, geeignet zur Hemmung der Phospholipase A2 | |
| NO803266L (no) | Alkylurinstoff-derivater til behandling av sykdommer i fettstoffskiftet, fremg.m. til deres fremst., deres anvend. i legemidler til behandl. av fettstoffskiftetforstyrrelser, legem. inneh. disse, og fremgm. til fremst. av legemidlene | |
| FI60392C (fi) | Foerfarande foer framstaellning av beta-(2-(p-klorfenoxi)-isobutyryloxi)-etylnikotinat | |
| GB2061274A (en) | 3-benzoyl-2-nitrophenylacetic acids metal salts amides and esters | |
| NZ199624A (en) | 1-(3-hydroxy-4-methoxybenzoyl)-3-hydroxy-2-pyrrolidine and pharmaceutical compositions | |
| JPH0526782B2 (enrdf_load_stackoverflow) | ||
| DE3688788T2 (de) | Benzazepinderivate. | |
| EP0296040B1 (en) | Actinonin derivatives having physiological activities | |
| JPH0374230B2 (enrdf_load_stackoverflow) | ||
| KR850000845B1 (ko) | 피롤리딘 유도체의 제조방법 | |
| EP1493734B1 (en) | Novel crystal form of 5-hydroxy-1-methylhydantoin | |
| JPS63119455A (ja) | グリシン誘導体 | |
| US4328235A (en) | Suppressing pain with benzothiazol-2(3H)-ones | |
| IL31915A (en) | Thiazolines, their preparation and pharmaceutical preparations containing them | |
| Fujii et al. | Facile syntheses of 4-(trifluoromethyl)-L-spinacine and 4-(trifluoromethyl) spinaceamine | |
| KR790001360B1 (ko) | α-[2-(P-클로로페녹시)-이소부티릴]-β-니코티노일 글리콜 에스테르의 제조방법 | |
| KR810000473B1 (ko) | N-2,6-디클로로페닐-2-아미노피리미딘의 제법 | |
| US3892800A (en) | Trichloroamino (and acylamino)phenylalkanoic acids and esters thereof | |
| EP0040433B1 (en) | Nicotinic derivatives of glucosamine, process for their preparation and related pharmaceutical compositions | |
| KR20150042275A (ko) | 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-l-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법 | |
| FR2649981A1 (fr) | Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant | |
| EP0058009A1 (en) | Novel benzanilide derivatives and pharmaceutical compositions containing them | |
| CA1048495A (en) | Benzodiazepine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: MERZ + CO., GMBH & CO. |